(Webinar date: February 4, 2016) This webinar focuses on the changes to the calculation of Average Manufacturer Price (AMP) for products reimbursed through the Medicaid Program.

Designed for distributor and manufacturer representatives as well as key industry stakeholders affected by the AMP ruling, topics include the treatment of bona fide service fees, any changes in the metrics to determine sales to retail community pharmacies, Federal Upper Limits (FULs) for multisource generic products, reimbursement for 5i products (infused, instilled, implanted, injected, inhaled) and any other changes to the AMP metric that may impact pharmacy reimbursement.

Speakers: Patrick Kelly, Executive Vice President, Government Affairs, HDMA
Stephanie Trunk, Partner, Arent Fox LLP